HNRNPD/AUF1 anticorps (AA 18-355)
-
- Antigène Voir toutes HNRNPD/AUF1 (HNRNPD) Anticorps
- HNRNPD/AUF1 (HNRNPD) (Heterogeneous Nuclear Ribonucleoprotein D (HNRNPD))
-
Épitope
- AA 18-355
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp HNRNPD/AUF1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Heterogeneous nuclear ribonucleoprotein D0 protein (18-355AA)
- Isotype
- IgG
- Top Product
- Discover our top product HNRNPD Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- HNRNPD/AUF1 (HNRNPD) (Heterogeneous Nuclear Ribonucleoprotein D (HNRNPD))
- Autre désignation
- HNRNPD (HNRNPD Produits)
- Synonymes
- anticorps AUF1, anticorps AUF1A, anticorps HNRPD, anticorps P37, anticorps hnRNPD0, anticorps Auf1, anticorps Hnrnpd, anticorps HNRNPD, anticorps p37, anticorps auf1a, anticorps hnrpd, anticorps hnrnpd0, anticorps C230004L04, anticorps Hnrpd, anticorps wu:fa28b06, anticorps zgc:162951, anticorps heterogeneous nuclear ribonucleoprotein D, anticorps heterogeneous nuclear ribonucleoprotein D L homeolog, anticorps HNRNPD, anticorps Hnrnpd, anticorps hnrnpd, anticorps hnrnpd.L
- Sujet
-
Background: Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3\\\'-UTR of many proto-oncogenes and cytokine mRNAs. Also binds to double- and single-stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5\\\'-UUAG-3\\\' sequence and also weaker to the single-stranded 5\\\'-TTAGGG-3\\\' telomeric DNA repeat. Binds RNA oligonucleotides with 5\\\'-UUAGGG-3\\\' repeats more tightly than the telomeric single-stranded DNA 5\\\'-TTAGGG-3\\\' repeats. Binding of RRM1 to DNA inhibits the formation of DNA quadruplex structure which may play a role in telomere elongation. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain.
Aliases: ARE binding protein AUFI type A antibody, AU-rich element RNA-binding protein 1 antibody, AUF antibody, AUF1 antibody, AUF1A antibody, Heterogeneous nuclear ribonucleoprotein D0 antibody, hnRNP D antibody, hnRNP D0 antibody, Hnrnpd antibody, hnRNPD0 antibody, HNRPD antibody, HNRPD_HUMAN antibody, P37 antibody
- UniProt
- Q14103
-